Tesla (NASDAQ:TSLA) shares rose 2.5% today, but the stock remains down ~17% year-to-date, suggesting the post-election ...

Oppenheimer analyst Jason Helfstein maintained a Buy rating on Trade Desk (TTD – Research Report) yesterday and set a price target of $115.00.

Amgen, Inc. ( NASDAQ: AMGN) Oppenheimer 35th Annual Healthcare Life Sciences Conference Call February 12, 2025 11:20 AM ET Narimon Honarpour - Senior Vice President, Global Development Justin Claeys - ...

Johnny Depp as Captain Jack Sparrow? Robert Downey Jr. in "Tropic Thunder"? You'd be shocked by the roles that have received ...

Fintel reports that on February 11, 2025, Oppenheimer initiated coverage of International Business Machines (NYSE:IBM) with a ...

Analysts at Oppenheimer said in a research note on Tuesday that billionaire Elon Musk's recent bid for ChatGPT parent OpenAI ...

Peter Oppenheimer, Goldman Sachs chief global equity strategist and head of macro research, joins 'Squawk Box' to discuss the latest market trends, why he believes that markets are vulnerable to a ...

Tesla (TSLA) is advancing 3% after investment bank Benchmark started coverage of the automaker with a Buy rating.

Investing.com -- Oppenheimer analysts warned that Tesla (NASDAQ: TSLA) faces rising risks as competition in both electric and ...

Stock analysts at Leerink Partnrs reduced their FY2024 EPS estimates for shares of United Therapeutics in a research note issued on Tuesday, February 11th. Leerink Partnrs analyst R. Ruiz now expects ...

As of now, “Anora” is the clear frontrunner thanks to wins with the Producers Guild and the Directors Guild — both prizes ...

The New York Stock Exchange and the Nasdaq have dominated the lucrative U.S. listings market in a virtual duopoly since the ...